Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Switching from TAF to TDF may help people lose weight, but this must be balanced against the risk of kidney problems and bone loss.
The updated guidance says antiretroviral therapy should be started as soon as possible after diagnosis and outlines the latest options.
Although 71% of survey respondents were aware of PrEP, just 19% had ever used HIV prevention pills.
Research on links between tenofovir, SARS-CoV-2 infection and COVID severity have yielded mixed results, but new study suggests it helps.
Children born to mothers on PrEP appeared to have normal growth and cognitive development.
The prevention pills—and newer methods—have averted countless HIV cases, but they still aren’t reaching everyone who could benefit.
The PrEP 2-1-1 regimen offers an option to take HIV prevention pills before and after sex instead of every day.
Under provisions of the Affordable Care Act, insurers must cover costs related to PrEP.
Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.
Many women could benefit from pre-exposure prophylaxis to prevent HIV.
People who took daily Truvada 90% to 100% of the time were more likely to develop osteopenia or osteoporosis.
Switching from TDF to TAF was associated with a less favorable blood fat profile.
People who switched to such a regimen gained up to 10 pounds in nine months.
Previous studies of the association between tenofovir and the coronavirus have yielded mixed results.
Previous studies of the association between tenofovir and COVID-19 outcomes in people with HIV have yielded mixed results.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.